Pembrolizumab trials for Head and Neck Squamous Cell Carcinoma

All Pembrolizumab trials · All Head and Neck Squamous Cell Carcinoma trials

Phase breakdown

Recruiting trials studying Pembrolizumab for Head and Neck Squamous Cell Carcinoma

• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
  NCT05859074 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
  NCT05913388 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
  NCT06047379 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
  NCT04429542 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations

Common questions

How many trials study Pembrolizumab for Head and Neck Squamous Cell Carcinoma?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.